Michela Brambatti, M.D.Director, Clinical Development at Ionis Pharmaceuticals
Michela Brambatti is a board-certified cardiologist and currently Associate Director in the Clinical Development department at Ionis Pharmaceuticals in Carlsbad, California. At Ionis, she focuses on early and late phase drug development for cardiac amyloidosis, HFrEF, and HFpEF. Before joining Ionis, she worked in the Department of Medicine at the University of California San Diego where she made significant contributions in natural history studies and the early development of gene therapy for Danon Disease. She published over 40 peer-reviewed manuscripts in the field of heart failure and rare cardiomyopathies. She completed medical school and cardiology fellowship at the Marche Polytechnic University (Italy), a research fellowship in cardiovascular epidemiology at McMaster University (Canada), and an MS degree at the University of California, San Diego.